CASP1 and neoplasm: We found that tumour-infiltrating CD11b+ myeloid cells from DIO mice had increased CASP1 processing but neither in CD11b+ cells from ND tumours nor in CD11b− cells (Fig. 3c and Supplementary Fig. 4e, left panels).